Annals of Medicine is an online, open access, international journal publishing across 33 areas of medicine and is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team, with guaranteed response times of within 48 hours.
The journal promotes collaboration across therapy areas and the open sharing of research. Combined with its scope covering translational medicine to clinical practice, Annals of Medicine is the home for researchers dedicated to supporting medical professionals in advancing practice for patients worldwide.
Accepting original research articles, review articles, clinical trials, protocols, case series and commentaries, the journal welcomes the submission of negative and null results, and reproducibility studies. Letters to the Editor are also considered and should discuss an analysis of an article previously published in Annals of Medicine.
Case reports are not accepted. Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype.
When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors' own data through replication in an original sample. Consideration of studies utilizing publicly available data is at the discretion of the Editor.
Pharmacological studies based solely on in silico analyses without experimental validation are not considered.
Bibliometric analyses and scoping reviews are not considered.
The journal welcomes submissions to the following sections:
Peer review statement
All submitted manuscripts are subject to initial appraisal by the Editorial Team and, if found suitable for further consideration, to single anonymized peer review by independent, expert referees.
According to the STM definitions and terminology for peer review practices, the following summary describes the peer review processes for this journal:
Standard Submissions to the journal - Single Anonymized Peer Review
Identity transparency: single anonymized
Reviewer interacts with: Editor
Review information published: None
Post publication commenting: None
Submission included in the ChinaXiv Open Review Pilot – Open Peer Review
Submissions which are included in the ChinaXiv Open Review pilot will be subject to initial appraisal by the Editorial team and, if found suitable for consideration, to open peer review by independent, expert referees. Under this open peer review pilot model:
- All identities are visible to each other (Decision-making Editor, Reviewer, Author);
- Reviewer and Author interacts with Decision-making Editor only;
- All reviewer reports are published on ChinaXiv;
- All submitted manuscripts and revised versions are published on ChinaXiv;
- Editor communication with Author (e.g., Editor decision letter) are also published on ChinaXiv;
- Manuscripts which have been peer reviewed and accepted will be published in Annals of Medicine.
Identity transparency: all identities visible
Reviewer interacts with: Editor
Review information published: Review reports, Submitted manuscript, Reviewer identities, Author/Editor communication, Editor identities (all published on ChinaXiv platform)
Post publication commenting: None
Read the Instructions for Authors for information on how to submit your article.
*Please note that Annals of Medicine converted to a fully Open Access journal beginning with Volume 53 (2021). The 1997-2020 volumes will be free to access from 1 January 2021
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})